{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:44:22Z","timestamp":1787039062828,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"LLC"},{"name":"CAT"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.envres.2019.109026","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T01:58:59Z","timestamp":1576461539000},"page":"109026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Nonlinear dose-time-response functions and health-protective exposure limits for inflammation-mediated diseases"],"prefix":"10.1016","volume":"182","author":[{"suffix":"Jr.","given":"Louis Anthony","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.envres.2019.109026_bib100","first-page":"627","article-title":"Changing Patterns of Pneumoconiosis Mortality - United States, 1968-2000","volume":"53","author":"Attfield","year":"2004","journal-title":"MMWR. Morbidity and mortality weekly report"},{"issue":"5","key":"10.1016\/j.envres.2019.109026_bib1","first-page":"117","article-title":"Silicosis mortality trends and new exposures to respirable crystalline silica - United States, 2001-2010","volume":"64","author":"Bang","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"8","key":"10.1016\/j.envres.2019.109026_bib2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nat. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.envres.2019.109026_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxlet.2011.04.026","article-title":"Bonvallot N Haber's rule duration adjustments should not be used systematically for risk assessment in public health decision-making","volume":"204","author":"Belkebir","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.envres.2019.109026_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijheh.2008.08.001","article-title":"Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma","volume":"212","author":"Betti","year":"2009","journal-title":"Int. J. Hyg Environ. Health"},{"issue":"2","key":"10.1016\/j.envres.2019.109026_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1559325819847834","article-title":"Inflammation as a cancer Co-initiator: new mechanistic model predicts low\/negligible risk at noninflammatory carcinogen doses","volume":"17","author":"Bogen","year":"2019","journal-title":"Dose Response"},{"issue":"1","key":"10.1016\/j.envres.2019.109026_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.envres.2019.109026_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/1559325818779651","article-title":"It Is Time to Move Beyond the Linear No-Threshold Theory for Low-Dose Radiation Protection","volume":"116","author":"Cardarelli","year":"2018","journal-title":"Dose Response"},{"issue":"9","key":"10.1016\/j.envres.2019.109026_bib6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1517\/14728222.2011.599801","article-title":"The role of inflammation in the pathogenesis of lung cancer","volume":"15","author":"Cho","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.envres.2019.109026_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0046-8177(82)80227-X","article-title":"Fiber counting and analysis in the diagnosis of asbestos-related disease","volume":"13","author":"Churg","year":"1982","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.envres.2019.109026_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.yrtph.2015.05.002","article-title":"Analysis of workplace compliance measurements of asbestos by the U.S. Occupational Safety and Health Administration (1984-2011)","volume":"72","author":"Cowan","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.envres.2019.109026_bib8","first-page":"263","article-title":"Isoprene cancer risk and the time pattern of dose administration","volume":"113","author":"Cox","year":"1996","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.envres.2019.109026_bib35","first-page":"353","article-title":"Universality of J-shaped and U-shaped dose-response relations as emergent properties of stochastic transition systems","volume":"3","author":"Cox","year":"2006","journal-title":"Dose Response"},{"issue":"2","key":"10.1016\/j.envres.2019.109026_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1559325819836900","article-title":"Risk analysis implications of dose-response thresholds for NLRP3 inflammasome-mediated diseases: respirable crystalline silica and lung cancer as an example","volume":"17","author":"Cox","year":"2019","journal-title":"Dose-Response"},{"issue":"1","key":"10.1016\/j.envres.2019.109026_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/17513758.2017.1355489","article-title":"A dynamical model of the transport of asbestos fibres in the human body","volume":"11","author":"DeStefano","year":"2017","journal-title":"J. Biol. Dyn."},{"key":"10.1016\/j.envres.2019.109026_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-8977-7-5","article-title":"Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma","volume":"7","author":"Donaldson","year":"2010","journal-title":"Part. Fibre Toxicol."},{"issue":"7","key":"10.1016\/j.envres.2019.109026_bib46","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/bjc.2013.514","article-title":"The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)","volume":"109","author":"Frost","year":"2013","journal-title":"Br. J. Cancer."},{"issue":"5","key":"10.1016\/j.envres.2019.109026_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/oemed-2015-103074","article-title":"Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden","volume":"73","author":"Gilham","year":"2016","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.envres.2019.109026_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-0348-0837-8_1","article-title":"The role of inflammation in lung cancer","volume":"816","author":"Gomes","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.envres.2019.109026_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cels.2016.04.016","article-title":"Distinct NF-\u03baB and MAPK activation thresholds uncouple steady-state microbe sensing from anti-pathogen inflammatory responses","volume":"2","author":"Gottschalk","year":"2016","journal-title":"Cell Syst."},{"key":"10.1016\/j.envres.2019.109026_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/JIR.S141220","article-title":"Spotlight on the NLRP3 inflammasome pathway","volume":"11","author":"Groslambert","year":"2018","journal-title":"J. Inflamm. Res."},{"issue":"24","key":"10.1016\/j.envres.2019.109026_bib17","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/jnci\/88.24.1853","article-title":"Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders","volume":"88","author":"Hirvonen","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.envres.2019.109026_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1940-6207.CAPR-15-0347","article-title":"Inflammation-related IL1\u03b2\/IL1R signaling promotes the development of asbestos-induced malignant mesothelioma","volume":"9","author":"Kadariya","year":"2016","journal-title":"Cancer Prev. Res."},{"issue":"2","key":"10.1016\/j.envres.2019.109026_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2326-6066.CIR-16-0269","article-title":"Inflammasomes and cancer","volume":"5","author":"Karki","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.envres.2019.109026_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/bib\/bbt077","article-title":"Investigating biocomplexity through the agent-based paradigm","volume":"16","author":"Kaul","year":"2015","journal-title":"Brief Bioinform"},{"issue":"1","key":"10.1016\/j.envres.2019.109026_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0041-008X(03)00225-4","article-title":"Area under the curve as a dose metric for promotional responses following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure","volume":"191","author":"Kim","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.envres.2019.109026_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/oemed-2013-101555","article-title":"Genes involved in innate immunity associated with asbestos-related fibrotic changes","volume":"71","author":"Kukkonen","year":"2014","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.envres.2019.109026_bib47","first-page":"15","article-title":"Biological and statistical approaches to predicting human lung cancer risk from silica","volume":"1","author":"Kuempel","year":"200120","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"3","key":"10.1016\/j.envres.2019.109026_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.00049810","article-title":"Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes","volume":"38","author":"Kukkonen","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.envres.2019.109026_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jtbi.2019.07.006","article-title":"Stochastic modelling of multistage carcinogenesis and progression of human lung cancer","volume":"479","author":"Li","year":"2019","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.envres.2019.109026_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6608a3","article-title":"Malignant mesothelioma mortality \u2014 United States, 1999\u20132015","volume":"66","author":"Mazurek","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"suppl 1","key":"10.1016\/j.envres.2019.109026_bib44","first-page":"S69","article-title":"Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models","volume":"32","author":"McCarthy","year":"2012","journal-title":"Risk Analysis"},{"key":"10.1016\/j.envres.2019.109026_bib51","first-page":"1","article-title":"Inflammatory mechanisms in the lung","volume":"2","author":"Moldoveanu","year":"2009","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.envres.2019.109026_bib36","series-title":"Randomized Algorithms","author":"Motwani","year":"1995"},{"key":"10.1016\/j.envres.2019.109026_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fimmu.2018.00103","article-title":"Macrophage recognition of crystals and nanoparticles","volume":"9","author":"Nakayama","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2019.109026_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2016.00097","article-title":"Silica, Silicosis, and Autoimmunity","volume":"7","author":"Pollard","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.envres.2019.109026_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s004200000202","article-title":"Inorganic fibres in the lung tissue of Hungarian and German lung cancer patients","volume":"74","author":"R\u00f6delsperger","year":"2001","journal-title":"Int. Arch. Occup. Environ. Health."},{"key":"10.1016\/j.envres.2019.109026_bib27","first-page":"91","article-title":"Silicosis and lung cancer: current perspectives","volume":"9","author":"Sato","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.envres.2019.109026_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12989-016-0162-4","article-title":"The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases","volume":"13","author":"Sayan","year":"2016","journal-title":"Part. Fibre Toxicol."},{"issue":"11\u201312","key":"10.1016\/j.envres.2019.109026_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/15287390590912586","article-title":"Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose","volume":"68","author":"Simmons","year":"2005","journal-title":"J. Toxicol. Environ. Health"},{"issue":"3","key":"10.1016\/j.envres.2019.109026_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ajpath.2016.11.008","article-title":"Asbestos-induced mesothelial to fibroblastic transition is modulated by the inflammasome","volume":"187","author":"Thompson","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.envres.2019.109026_bib31","series-title":"Mesothelioma Mortality in Great Britain the Revised Risk and Two-Stage Clonal Expansion Models Prepared by the Health and Safety Laboratory for the Health and Safety Executive","author":"Tan","year":"2011"},{"key":"10.1016\/j.envres.2019.109026_bib32","series-title":"A Biomathematical Model for Rodent and Human Lung Describing Exposure, Dose, and Response to Inhaled Silica","author":"Tran","year":"2001"},{"issue":"Supplement 1","key":"10.1016\/j.envres.2019.109026_bib49","first-page":"1","article-title":"A rat lung model of exposure, dose and response to inhaled silica","volume":"46","author":"Tran","year":"2002","journal-title":"Ann. Occup. Hyg."},{"issue":"3","key":"10.1016\/j.envres.2019.109026_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajim.4700160303","article-title":"Mineral fiber concentration in lung tissue of mesothelioma patients in Finland","volume":"16","author":"Tuomi","year":"1989","journal-title":"Am. J. Ind.Med."},{"issue":"8","key":"10.1016\/j.envres.2019.109026_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/oem.2009.053983","article-title":"The two-stage clonal expansion model in occupational cancer epidemiology: results from three cohort studies","volume":"68","author":"Zeka","year":"2011","journal-title":"Occup. Environ. Med."}],"container-title":["Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935119308230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935119308230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:22:27Z","timestamp":1757967747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013935119308230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":46,"alternative-id":["S0013935119308230"],"URL":"https:\/\/doi.org\/10.1016\/j.envres.2019.109026","relation":{},"ISSN":["0013-9351"],"issn-type":[{"value":"0013-9351","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonlinear dose-time-response functions and health-protective exposure limits for inflammation-mediated diseases","name":"articletitle","label":"Article Title"},{"value":"Environmental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envres.2019.109026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109026"}}